Vaccinex (VCNX) Stock Forecast, Price & News

Vaccinex (NASDAQ:VCNX) Frequently Asked Questions

Are investors shorting Vaccinex?

Vaccinex saw a decrease in short interest in the month of April. As of April 30th, there was short interest totaling 564,800 shares, a decrease of 23.3% from the April 15th total of 736,100 shares. Based on an average daily volume of 299,800 shares, the days-to-cover ratio is currently 1.9 days. Approximately 4.2% of the company's shares are short sold.
View Vaccinex's Short Interest.

When is Vaccinex's next earnings date?

Vaccinex is scheduled to release its next quarterly earnings announcement on Monday, August 15th 2022.
View our earnings forecast for Vaccinex.

How were Vaccinex's earnings last quarter?

Vaccinex, Inc. (NASDAQ:VCNX) announced its quarterly earnings data on Thursday, March, 31st. The company reported ($0.15) earnings per share (EPS) for the quarter.
View Vaccinex's earnings history.

Who are Vaccinex's key executives?

Vaccinex's management team includes the following people:

• Dr. Maurice Zauderer Ph.D., Co-Founder, CEO, Pres & Director (Age 76, Pay $374.9k) (LinkedIn Profile)
• Mr. Scott E. Royer C.F.A., M.B.A., Chief Financial Officer (Age 48, Pay $242.15k)
• Dr. Ernest S. Smith Ph.D., Sr. VP of Research & Chief Scientific Officer (Age 50, Pay $264.74k)
• Dr. Deepak M. Sahasrabudhe, Co-Founder, Sr. Mang. of Laboratory Operations & Safety and Scientific & Clinical Advisor
• Dr. Elizabeth E. Evans Ph.D., COO and Sr. VP of Discovery & Translational Medicine (Age 49)
• Dr. John E. Leonard Ph.D., Sr. VP of Devel. (Age 75)

Who are some of Vaccinex's key competitors?

Some companies that are related to Vaccinex include Nanobiotix (NBTX), Entrada Therapeutics (TRDA), Harrow Health (HROW), Immunic (IMUX), Omeros (OMER), Pliant Therapeutics (PLRX), Oramed Pharmaceuticals (ORMP), XBiotech (XBIT), Theratechnologies (THERF), Viking Therapeutics (VKTX), Verrica Pharmaceuticals (VRCA), Rezolute (RZLTD), Clene (CLNN), Rhythm Pharmaceuticals (RYTM) and LumiraDx (LMDX).
View all of VCNX's competitors.

What other stocks do shareholders of Vaccinex own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Vaccinex investors own include VBI Vaccines (VBIV), OPKO Health (OPK), Aldeyra Therapeutics (ALDX), Sorrento Therapeutics (SRNE), Cerecor (CERC), Exelixis (EXEL), Pfizer (PFE), AVEO Pharmaceuticals (AVEO), Heat Biologics (HTBX) and SCYNEXIS (SCYX).

When did Vaccinex IPO?

(VCNX) raised $45 million in an initial public offering on Thursday, August 9th 2018. The company issued 3,300,000 shares at $12.00-$15.00 per share. Oppenheimer and BTIG acted as the underwriters for the IPO and Ladenburg Thalmann was co-manager.

What is Vaccinex's stock symbol?

Vaccinex trades on the NASDAQ under the ticker symbol "VCNX."

Who are Vaccinex's major shareholders?

Vaccinex's stock is owned by a variety of institutional and retail investors. Top institutional investors include AIGH Capital Management LLC (4.88%), Vanguard Group Inc. (1.70%), Worth Venture Partners LLC (0.16%), Group One Trading L.P. (0.00%), Concourse Financial Group Securities Inc. (0.00%) and Simplex Trading LLC (0.00%). Company insiders that own Vaccinex stock include Albert Friedberg, Jacob B Frieberg, Maurice Zauderer and Strydonck Gerald E Van.
View institutional ownership trends for Vaccinex.

Which institutional investors are selling Vaccinex stock?

VCNX stock was sold by a variety of institutional investors in the last quarter, including Group One Trading L.P., and Simplex Trading LLC.
View insider buying and selling activity for Vaccinex or view top insider-selling stocks.

Which institutional investors are buying Vaccinex stock?

VCNX stock was bought by a variety of institutional investors in the last quarter, including AIGH Capital Management LLC, Vanguard Group Inc., and Worth Venture Partners LLC. Company insiders that have bought Vaccinex stock in the last two years include Albert Friedberg, Jacob B Frieberg, Maurice Zauderer, and Strydonck Gerald E Van.
View insider buying and selling activity for Vaccinex or or view top insider-buying stocks.

How do I buy shares of Vaccinex?

Shares of VCNX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Vaccinex's stock price today?

One share of VCNX stock can currently be purchased for approximately $1.13.

How much money does Vaccinex make?

Vaccinex has a market capitalization of $48.21 million and generates $900 thousand in revenue each year. The company earns $-22.38 million in net income (profit) each year or ($0.65) on an earnings per share basis.

How many employees does Vaccinex have?

Vaccinex employs 39 workers across the globe.

What is Vaccinex's official website?

The official website for Vaccinex is www.vaccinex.com.

How can I contact Vaccinex?

Vaccinex's mailing address is 1895 MOUNT HOPE AVENUE, ROCHESTER NY, 14620. The company can be reached via phone at (585) 271-2700, via email at [email protected], or via fax at 585-271-2765.